Weekly
π£π The next evolution: IMR β paeds FDA approval; TNE completes unison transform & Wyndhan City go-live; Homodeus on Bloomberg
HOMODEUS RESEARCH WEEKLY BRIEF Β· 4 July 2026 Research | Videos | Podcasts NH HDR <GO> Homodeus Research is now on Bloomberg. Access needs to be permissioned. Contact me for access Homodeus Research available on Bloomberg contact me for access Upcoming webinars Next week: Date | Time Time Event Company Details 6 July 2026 16:00AEST Semiconductor Industry Deep Dive ASX:A4N Link 8 July 2026 09:00 AEST Mach7 Technologies (ASX:M7T) | Webinar ASX:M7T Link 9 July 2026 11:00 AEST Manhattan Gold Corporation (ASX:MHC) ASX:MHC Link Research & Webinars this week: AlphaHPA (ASX:A4N) ASX:A4N Webinar ASX:TNE ReadyTech read-thru ASX:IMR FDA clearance of Paediatric use NEWS THIS WEEK Imricor (ASX:IMR, Valuation A$3/shr, +48% upside) has received FDA clearance for Northstar and Diagnostic Catheter for Paediatric use. The clearance opens up a new revenue category which is an attractive early commercial channel in advance of broader U.S. adoption of Imricor's full EP platform. We have a A$3 valuation on Imricor implying 66% upside to current market valuation. Source: Homodeus research Tech1 (ASX:TNE, Valuation A$39/shr, +30% upside) ReadyTech SMS read-thru: ReadyTech (ASX:RDY) has secured anβ¦